Delivery Order SPE2DB20D1100-SPE2DB23FD3G6
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $26K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,924.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561731251 DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor, Amerisourcebergen Drug Corporation located in Conshohocken, Pennsylvania, will deliver the requested pharmaceutical product under the terms of the delivery order, which runs from August 7-8, 2023. The Defense Logistics Agency will provide funding for this delivery of DUPIXENT 300 MG/2 ML pens to support its...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,609.44 to Amerisourcebergen Drug Corporation for the purchase of 4562002758 DUPIXENT 300 MG/2 ML PEN 2ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. The order is funded by the Defense Logistics Agency and supports the agency's medical supply chain and...
- The Defense Logistics Agency awarded a $24,164.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562194692 DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 in support of the Defense Logistics Agency's medical supply chain operations. Amerisourcebergen Drug Corporation will perform the contract from its corporate office in Conshohocken. No subcontractors or...
- The Defense Logistics Agency awarded a $21,253 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561585392 DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a period of performance of one day, from July 24, 2023 to July 25, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in...
- The Defense Logistics Agency awarded a $8,420.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561464911 DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under a period of performance spanning July 11 through July 12, 2023. No set aside designation or subcontracting details were provided....
- The Defense Logistics Agency Troop Support Medical awarded a $15,835 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561889552 units of DUPIXENT 300 MG/2 ML PEN 2ML to be delivered to a location in Conshohocken, Pennsylvania by August 22, 2023. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment. This delivery order was issued under an existing...
- The Defense Logistics Agency awarded a $24,436 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561377681 DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under a one day period of performance between June 29-30, 2023. No additional details were provided regarding the original solicitation or...
- The Defense Logistics Agency awarded a $24,087.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency awarded a $5,538.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562126848 DUPIXENT 300 MG/2 ML PEN 2ML. The delivery order is being carried out under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health care programs. Amerisourcebergen will deliver the specified pharmaceutical product from its facility in Conshohocken, Pennsylvania to an...
- The Defense Logistics Agency awarded a $17,579 delivery order to Amerisourcebergen Drug Corporation for 4561327588 DUPIXENT 300 MG/2 ML PEN 2ML. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning June 23 through June 26, 2023. DLA will utilize the pharmaceutical products under the order to support its medical supply chain initiatives. As the prime contractor, Amerisourcebergen will leverage its established...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD3G6Delivery Order
The Defense Logistics Agency awarded a $25,684.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561984121 DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor, Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its place of performance in Conshohocken, Pennsylvania to support Defense Logistics Agency requirements. The delivery order, issued under an existing DLA pharmaceuticals contract vehicle, has a period of performance from August 29, 2023 through August 30, 2023.
Generated 12/20/23, 11:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 8/29/23 |